Goldman Sachs’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.32M Buy
473,384
+103,566
+28% +$869K ﹤0.01% 3849
2025
Q4
$2.75M Sell
369,818
-22,582
-6% -$162K ﹤0.01% 4296
2025
Q3
$2.63M Buy
392,400
+255,769
+187% +$1.77M ﹤0.01% 4242
2025
Q2
$904K Sell
136,631
-25,781
-16% -$183K ﹤0.01% 4776
2025
Q1
$1.49M Buy
162,412
+26,103
+19% +$261K ﹤0.01% 4388
2024
Q4
$1.43M Sell
136,309
-25,964
-16% -$307K ﹤0.01% 4567
2024
Q3
$1.94M Buy
162,273
+46,068
+40% +$398K ﹤0.01% 4180
2024
Q2
$668K Sell
116,205
-98,124
-46% -$538K ﹤0.01% 4667
2024
Q1
$1.11M Buy
214,329
+179,943
+523% +$879K ﹤0.01% 4275
2023
Q4
$181K Buy
+34,386
New +$136K ﹤0.01% 5181
2023
Q3
Sell
-14,008
Closed -$40.5K 5564
2023
Q2
$40.5K Buy
14,008
+3,861
+38% +$7.41K ﹤0.01% 5483
2023
Q1
$10.9K Sell
10,147
-29,090
-74% -$55.6K ﹤0.01% 5734
2022
Q4
$102K Sell
39,237
-125,556
-76% -$548K ﹤0.01% 5475
2022
Q3
$1.15M Buy
164,793
+108,130
+191% +$847K ﹤0.01% 4406
2022
Q2
$386K Buy
56,663
+10,090
+22% +$103K ﹤0.01% 5264
2022
Q1
$657K Buy
46,573
+5,538
+13% +$74.1K ﹤0.01% 5147
2021
Q4
$594K Buy
+41,035
New +$583K ﹤0.01% 5255

Other funds holding BVS